The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for KARL STORZ SE sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
KARL STORZ SE & Co KG (Karl Storz) manufactures and distributes endoscopes, surgical devices, and medical instruments. The company offers rigid and flexible endoscopes, and other instruments for the field of human medicine used for neurosurgery; oral and maxillofacial surgery; ear, nose, and throat plastic surgery; cardiovascular surgery; anesthesiology and emergency medicine; thorax; gastroenterology and others. The company provides industrial endoscopes for non-destructive testing including video scopes, cameras, borescopes and documentation systems. It also offers endoscopy systems for all areas of veterinary medicine. The company markets products through a network of subsidiaries and distributors in the Americas, Europe, Africa, the Middle East, Asia, and Oceania. Karl Storz is headquartered in Tuttlingen, Germany. Key subsidiaries of KARL STORZ SE include KARL STORZ Veterinary Endoscopy America, KARL STORZ Endoscopy Belgium, KARL STORZ Endoscopie Nederland, KARL STORZ Endoskop Sverige and KARL STORZ Endoscopy (Shanghai).
The key metrics of KARL STORZ SE related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As KARL STORZ SE is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as KARL STORZ SE.
For a detailed understanding of the performance of KARL STORZ SE, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
